by Nico Konrad
The problem we solve: Doctors/clinics: -Shortage of fundamental services -Lack of time and attention -Low reliability of analysis due to episodic, reactive and unconnected treatment Expecting Mothers: -Loss of time away from work and childcare -Personal anxiety and stress -Lack of continuous support -Fear of frequent hospital visits due to infection risks (aggravated by COVID-19)
About our solution: Product Benefits: -Small and easy to handle -Reviewing of data history and real-time insight in current data stream -Secure data cloud storage -High reliability of information/ measurement -Easy „Plug and play” (no setup needed) -Early detection of potential complications Patient Benefits: - Safety & Certainty - Stress minimization & Comfort - Enable rapid decision making -Reduction of pregnancy related absence from work Doctors and Midwives Benefits: -Additional income -Full and remote patient history access -Reduction of queues and increased doctor availability -USP to other obstetrics practices Overall: 1. More safety & convenience 2. Less cost & hassle 3. Better clinical outcomeProgress to date:
Nestmedic is in the last stages of finalizing their next Product Pregnabit®Pro and start a global scalable sales campaign in the USA after FDA approval.
36 customers and 115 devices currently operating on the market with over 12 000 tests in Poland and in Europe.
Pregnabit has become a very valuable solution during the global COVID-19 pandemic: Over 70 new contracts in B2C model in Q2/2020 and an increase of 257% compared to Q1.
Hospitals, private healthcare, insurers and midwives appreciate Pregnabit: limits visits and hospitalizations of pregnant women.
Various Venture Funds and Private Equity companies believe in Nestmedic’s business model and have invested EUR 3 million.
Additionally, a grant of EUR 850k from the European Union has been received to boost research and development.
Funding needed for acceleration of geographical expansion with access to over 6 million potential end-users* in the EU and especially in the US after FDA approval.
Creator: Nico Konrad
Location: Berry Islands
Education: University of Mannheim - M.Sc.
Bio: I am convinced of PhD management with many years of experience in -managing production, service and technology companies in the medical industry -35 years experience in founding/ running/ managing IT companies & creating IT solutions. -managing and developing telemedicine products in companies such as InfoScan,Cardio.link and EFM -10 years of experience in quality and regulations for medical devices at BD, PRO-PHARM and USP.
Title: Investor Relations Manager
Biography: Chairman of the Management Board w Nestmedic S.A. A financier by education. Many years of experience in managing production, service and technology companies in the medical industry such as IMPAQ, Infoscan and Impera Capital. He specializes in strategic, financial and operational management.
Advanced Degree(s): BA
"70% prefer using a digital solution to monitor their health metrics at home.“- McKinsey & Company
"Personalized Technology will upend the Doctor Patient Relationship“ - Harvard Business Review
"80 percent of the things doctors do today will be done by machines” - Vinod Khosla: billionaire investor
"From USD 111.4 billion in 2019, the global digital health market is predicted to grow to USD 510.4 billion by 2025, registering a CAGR of 29.0% during the forecast period (2020–2025)” - Zion Research, July 2018
"The cumulative costs of childbirth is estimated at well over USD 50 billion annually in the US alone. - The New York Times, June 2013
"540,000 babies are annually born preterm in the US alone with a total annual burden of more than USD 26 billion. - The National Academy of Medicine
Projected 3 Year Growth
By providing the medical device and access to the analysis platform to doctors, clinics/hospitals, distributors (B2B) or directly to pregnant women (B2C) for a compensation of
- €3999 up-front + €49-99 monthly or
-24 monthly installments payment of €199 + €99 monthly
-Rental only for patients €99 / 2 weeks
Pregnabit outperforms the competition in tech and user-friendliness
Please note that access to the company's confidential materials is limited. Click this button to request access from the Company and its representatives.
Great project! Very important for the mother-to-be, especially during a pandemic
An amazing medical device dedicated to pregnant women! During the pandemic, telemedicine is very important as it helps patients stay at home and still remain under medical supervision.
No updates found .
Help us find best new ideas to fund by telling us what you think. Your feedback goes straight to the team behind this project in private, so tell them what you really think.